RecruitingNCT07006831
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
Sponsor
Devyser Inc.
Enrollment
400 participants
Start Date
Nov 14, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transplanted organ.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Willing and able to provide written informed consent
- Is 18 years of age or older at enrollment
- Had a kidney transplant prior to enrollment
- Is having an indication (for cause) biopsy as determined by clinician
- retrospective leftover samples are available from the kidney donor(s).
Exclusion Criteria6
- Is pregnant
- Had a blood transfusion within the past 4 weeks
- Had a transplant from an identical (monozygotic) twin
- Had transplants of multiple organs from the same donor (eg, kidney and liver transplant).
- Had transplants of more than 2 organs from different donors (eg, recipient of a third kidney transplant)
- Had a transplant of hematopoietic stem cells (eg, bone marrow) or tissue (eg, heart valve)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07006831
Related Trials
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
NCT06963827153 locations
Immune System Related Kidney Disease
NCT000019791 location
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
NCT06830798130 locations
Rutgers University Study of the Genetics of Kidney Disease
NCT072175351 location
Empagliflozin Treatment in Kidney Transplant Recipients
NCT060138655 locations